NF-κB pathways enhance cancer cell migration and invasion by upregulating multi-drug resistance genes, pro-angiogenic factors and pro-inflammatory cytokines such as VEGFA, EGF, IL-6 and IL-8 [105]. This evidence concerns the gene NFKB1 and cancer.